未登录 分享 收藏
分享 收藏
Outcomes and salvage strategies for large B-cell lymphoma progressing after second-line CAR T-cell therapy: A DESCAR-T study from the LYSA group 二线CAR T细胞治疗后进展的大B细胞淋巴瘤的结局和挽救策略：LYSA小组的DESCAR-T研究 Sesques, Pierre; Manson, Guillaume; Cartron, Guillaume; Gros, Francois-Xavier; Morschhauser, Franck; Castilla-Llorente, Cristina; Brisou, Gabriel; Bories, Pierre; Thieblemont, Catherine; La Rochelle, Laurianne Drieu; Tessoulin, Benoit; Andre, Axel; Rossi, Cedric; Paillassa, Jerome; Guidez, Stephanie; Capes, Antoine; Herbreteau, Laura; Choquet, Sylvain; Bay, Jacques-Olivier; Chauchet, Adrien; Lebras, Laure; Claves, Fabien; Abraham, Julie; Malfuson, Jean-Valere; Rubio, Marie-Therese; Decroocq, Justine; Fornecker, Luc-Matthieu; Damaj, Gandhi; Fouillet, Ludovic; Joris, Magalie; Loschi, Michael; Hermine, Olivier; Hafirassou, Hadia; Van Zele, Emelie; Dupont, Vivien; Le Gouill, Steven; Houot, Roch; Camus, Vincent 分享 收藏
Outcomes and treatment patterns of patients with primary mediastinal B-cell lymphoma after CAR-T cell therapy failure: A DESCAR-T analysis 原发性纵隔B细胞淋巴瘤患者在CAR-T细胞疗法失败后的结局与治疗模式：一项DESCAR-T分析 Galtier, Jean; Sesques, Pierre; Dupont, Vivien; Bachy, Emmanuel; Di Blasi, Roberta; Thieblemont, Catherine; Brisou, Gabriel; Gastinne, Thomas; Cartron, Guillaume; Gros, Francois-xavier; Morschhauser, Franck; Andre, Axel; Bay, Jacques-olivier; Joris, Magalie; Tanguy-schmidt, Aline; Demailly, Audrey; Le Gouill, Steven; Houot, Roch; Bouabdallah, Krimo; Camus, Vincent 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
T cell malignancies after CAR T cell therapy in the DESCAR-T registry (vol 31, pg 1130, 2025) CAR T细胞疗法后T细胞恶性肿瘤在DESCAR-T登记研究中的情况（卷31，页1130，2025） Dulery, Remy; Guiraud, Vincent; Choquet, Sylvain; Thieblemont, Catherine; Bachy, Emmanuel; Barete, Stephane; Todesco, Eve; Arnulf, Bertrand; Boissel, Nicolas; Baruchel, Andre; Bay, Jacques-Olivier; Le Gouill, Steven; Houot, Roch 分享 收藏
Prognostic impact of metabolic tumor volume using the SUV4.0 segmentation threshold in 1,960 lymphoma patients from prospective LYSA trials 使用SUV4.0分割阈值测量的代谢肿瘤体积对1960例来自前瞻性LYSA试验的淋巴瘤患者的预后影响 Malmon, Solene; Elsensohn, Mad-Helenie; Thieblemont, Catherine; Morschhauser, Franck; Casasnovas, Olivier; Andre, Marc; Gouill, Steven Le; Tabaa, Yassine Al; Durand, Paul Bland; Bailly, Clement; Edeline, Veronique; Vija, Lavinia; Vercellino, Laetitia; Ricci, Romain; Kanoun, Salim; Cottereau, Anne-Segolene 分享 收藏
分享 收藏
Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma treated with anti-CD19 CAR-T cells: CARTHYM, a study from the French national DESCAR-T registry 复发或难治性原发纵隔B细胞淋巴瘤患者接受抗CD19 CAR-T细胞治疗的结局：CARTHYM，一项来自法国国家DESCAR-T登记研究的报告 Galtier, Jean; Mesguich, Charles; Sesques, Pierre; Dupont, Vivien; Bachy, Emmanuel; Di Blasi, Roberta; Thieblemont, Catherine; Gastinne, Thomas; Cartron, Guillaume; Brisou, Gabriel; Gros, Francois-Xavier; Decroocq, Justine; Morschhauser, Franck; Rubio, Marie-Therese; La Rochelle, Laurianne Drieu; Le Bras, Fabien; Carras, Sylvain; Chauchet, Adrien; Bay, Jacques-Olivier; Joris, Magalie; Loschi, Mickael; Tanguy-Schmidt, Aline; Marquet, Alexandra; Camus, Vincent; Le Gouill, Steven; Houot, Roch; Bouabdallah, Krimo 分享 收藏
分享 收藏
Efficacy of anti-PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSA 抗PD1疗法在结外NK/T细胞淋巴瘤中的疗效：一项来自LYSA的匹配队列分析 Marouf, Amira; Chaubard, Sammara; Lievin, Raphael; Michot, Jean-Marie; Molinari, Nicolas; Rossignol, Julien; Cavalieri, Doriane; Golfier, Camille; Allangba, Olivier; Philippe, Laure; Tessoulin, Benoit; Chauchet, Adrien; Deau, Benedicte; Oberic, Lucie; Vargaftig, Jacques; Moignet, Aline; Clavert, Aline; Dulery, Remy; Brisou, Gabriel; Tardy, Stephanie; Fataccioli, Virginie; Houot, Roch; Casasnovas, Rene O.; Thieblemont, Catherine; Ghesquieres, Herve; Carras, Sylvain; Le Gouill, Steven; Cartron, Guillaume; Ribrag, Vincent; Cheminant, Morgane; Marcais, Ambroise; Suarez, Felipe; Marabelle, Aurelien; Tournilhac, Olivier; Damaj, Gandhi; Gaulard, Philippe; De Leval, Laurence; Lemonnier, Francois; Bachy, Emmanuel; Chevret, Sylvie; Hermine, Olivier; Couronne, Lucile; Jaccard, Arnaud 分享 收藏
Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma Di Staso, Rossana; Casadei, Beatrice; Locke, Frederick L.; Jain, Michael; Voorhees, Timothy J.; Kittai, Adam S.; Bastos-Oreiro, Mariana; Gutierrez, Antonio; Martin Garcia-Sancho, Alejandro; Terol, Maria Jose; Mead, Monica; Maranzano, Michael J.; Iacoboni, Gloria; Barba, Pere; Kwon, Mi; Bailen, Rebeca; Reguera-Ortega, Juan Luis; Mian, Agrima; Hill, Brian; Bachy, Emmanuel; Morschhauser, Franck; Houot, Roch; Thieblemont, Catherine; Le Gouill, Steven; Masetti, Riccardo; Gori, Davide; Broccoli, Alessandro; Zinzani, Pier Luigi; Argnani, Lisa 分享 收藏
Aberrant Cytoplasmic Expression of p16 Is a New Strong Prognostic Marker in Young MCL Patients Treated By Frontline Cytarabine-Based Immunochemotherapy, a Study from the Lysa Group, Nordic Lymphoma Group and the European MCL Network p16的异常细胞质表达是接受一线阿糖胞苷为基础的免疫化疗的年轻MCL患者的一个新的强预后标志物，一项来自Lysa Group、Nordic Lymphoma Group和European MCL Network的研究 Le Bris, Yannick; Burroni, Barbara; Fournier, Marguerite; Cheminant, Morgane; Ek, Sara; Hoster, Eva; Delfau-Larue, Marie-Helene; Sarkozy, Clementine; Callanan, Mary B.; Tessoulin, Benoit; Chiron, David; Dreyling, Martin; Jerkeman, Mats; Le Gouill, Steven; Hermine, Olivier 分享 收藏
Ibrutinib, Venetoclax Plus CD20 Monoclonal Ab Provides Very High MRD Negativity in Previously Untreated MCL Patients, Initial Results of OASIS II, a Randomized Phase 2 Trial 伊布替尼、维奈克拉联合CD20单克隆抗体为初治MCL患者提供极高的MRD阴性率，OASIS II随机II期试验初步结果。 Le Gouill, Steven; de Wilde, Virginie; Eyre, Toby A.; Callanan, Mary B.; Damaj, Gandhi; Claudel, Alexis; Chauchet, Adrien; Houot, Roch; Le Calloch, Ronan; Cacheux, Victoria; Andre, Marc; Morschhauser, Franck; Burroni, Barbara; Lewis, David John; Tessoulin, Benoit; Touzart, Aurore 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
BLOOD.png)
.png){kind=icon}
分享.png){kind=icon}
收藏